An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas

Journal of Pathology

Volumn 238, Issue 4, 2016, Pages 489-494

  McCart Reed, Amy E ^a   Kutasovic, Jamie R ^a   Vargas, Ana C ^a   Jayanthan, Janani ^a   Al Murrani, Amel ^a   Reid, Lynne E ^a   Chambers, Rachael ^a,b   Da Silva, Leonard ^a   Melville, Lewis ^a,c   Evans, Elizabeth ^d   Porter, Alan ^d   Papadimos, David ^b   Thompson, Erik W ^e,f   Lakhani, Sunil R ^a,c,g   Simpson, Peter T ^a,g  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d WESLEY HOSPITAL   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

breast cancer; E cadherin; epithelial to mesenchymal transition (EMT); invasive lobular carcinoma

Indexed keywords

FIBRONECTIN; NERVE CELL ADHESION MOLECULE; OSTEONECTIN; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VIMENTIN; CADHERIN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; BREAST CARCINOMA; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SNAIL; TUMOR CELL; TUMOR GROWTH; UPREGULATION; BREAST TUMOR; EPITHELIUM CELL; GENETICS; LUNG CARCINOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; TUMOR INVASION;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CADHERINS; CARCINOMA, LOBULAR; CELL LINE, TUMOR; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PHENOTYPE; TRANSCRIPTION FACTORS;

EID: 84959147400     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4668     Document Type: Article

References (23)

1. Thiery JP, Acloque H, Huang RY, et al., Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
2. Weigelt B, Ng CK, Shen R, et al., Metastatic breast carcinomas display genomic and transcriptomic heterogeneity. Mod Pathol 2015; 28: 340-351.
3. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, et al., Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989-997.
4. Taube JH, Herschkowitz JI, Komurov K, et al., Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 2010; 107: 15449-15454.
5. Hazan RB, Qiao R, Keren R, et al., Cadherin switch in tumor progression. Ann N Y Acad Sci 2004; 1014: 155-163.
6. Rakha EA, Ellis IO,. Lobular breast carcinoma and its variants. Semin Diagn Pathol 2010; 27: 49-61.
7. Schackmann RC, van Amersfoort M, Haarhuis JH, et al., Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. J Clin Invest 2011; 121: 3176-3188.
8. Micalizzi DS, Farabaugh SM, Ford HL,. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010; 15: 117-134.
9. Turashvili G, Bouchal J, Ehrmann J, et al., Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007; 151: 59-64.
10. Yang J, Mani SA, Donaher JL, et al., Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939.
11. Sarrio D, Moreno-Bueno G, Hardisson D, et al., Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 2003; 106: 208-215.
12. Tsai JH, Yang J,. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013; 27: 2192-2206.
13. Morrogh M, Andrade VP, Giri D, et al., Cadherin-catenin complex dissociation in lobular neoplasia of the breast. Breast Cancer Res Treat 2012; 132: 641-652.
14. Tarin D, Thompson EW, Newgreen DF,. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005; 65: 5996-6000; discussion 6000-6001.
15. Hollestelle A, Peeters JK, Smid M, et al., Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer. Breast Cancer Res Treat 2013; 138: 47-57.
16. Savagner P., The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol 2010; 21 (Suppl 7): vii89-92.
17. Zou D, Yoon HS, Anjomshoaa A, et al., Increased levels of active c-Src distinguish invasive from in situ lobular lesions. Breast Cancer Res 2009; 11: R45.
18. Chen A, Beetham H, Black MA, et al., E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition. BMC Cancer 2014; 14: 552.
19. Derksen PW, Liu X, Saridin F, et al., Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006; 10: 437-449.
20. Cerami E, Gao J, Dogrusoz U, et al., The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-404.
21. Gao J, Aksoy BA, Dogrusoz U, et al., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.
22. Lehmann BD, Bauer JA, Chen X, et al., Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011; 121: 2750-2767.
23. Prat A, Parker JS, Karginova O, et al., Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12: R68.